These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10084455)

  • 1. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
    Burgess DS
    Chest; 1999 Mar; 115(3 Suppl):19S-23S. PubMed ID: 10084455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies.
    Owens RC; Shorr AF
    Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S23-30. PubMed ID: 19502225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do we really know about antibiotic pharmacodynamics?
    Gunderson BW; Ross GH; Ibrahim KH; Rotschafer JC
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):302S-318S. PubMed ID: 11714222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How predictive is PK/PD for antibacterial agents?
    Frimodt-Møller N
    Int J Antimicrob Agents; 2002 Apr; 19(4):333-9. PubMed ID: 11978504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance.
    DeRyke CA; Lee SY; Kuti JL; Nicolau DP
    Drugs; 2006; 66(1):1-14. PubMed ID: 16398565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
    Bland CM; Pai MP; Lodise TP
    Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbial resistance to antibiotics from the clinical viewpoint. Paradoxical therapy failures and the significance of pharmacokinetic-pharmacodynamic interactions in vivo].
    Rossi M; Gerber AU
    Ther Umsch; 2002 Jan; 59(1):11-9. PubMed ID: 11851041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics.
    Toutain PL; del Castillo JR; Bousquet-Mélou A
    Res Vet Sci; 2002 Oct; 73(2):105-14. PubMed ID: 12204627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.
    Arnold A; Brouse SD; Pitcher WD; Hall RG
    J Intensive Care Med; 2010 Sep; 25(5):259-70. PubMed ID: 20622257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens.
    Craig W
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S6-8. PubMed ID: 8477766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotics: new and old drugs, rational prescription].
    de With K; Stocker H; Borde J; Kern WV
    Dtsch Med Wochenschr; 2012 Feb; 137(5):186-9. PubMed ID: 22278687
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacodynamics of antimicrobial therapy in surgery.
    DiPiro JT; Edmiston CE; Bohnen JM
    Am J Surg; 1996 Jun; 171(6):615-22. PubMed ID: 8678212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States.
    Koomanachai P; Bulik CC; Kuti JL; Nicolau DP
    Clin Ther; 2010 Apr; 32(4):766-79. PubMed ID: 20435246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling.
    Nicolau DP
    J Infect Chemother; 2003 Dec; 9(4):292-6. PubMed ID: 14691648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the dose matter?
    Craig WA
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S233-7. PubMed ID: 11524724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.